Long Acting Injectable Buprenorphine-Recording

Video Transcription

Video Summary

Chelsea's introduction in the video highlights the importance of recognizing indigenous lands, followed by Dr. Sarah Spencer's presentation on long-acting injectable buprenorphine for addiction treatment, particularly in Alaska. The talk discusses the medication's benefits, logistical aspects, administration techniques, patient satisfaction, and transitioning from sublingual buprenorphine. Dr. Spencer emphasizes the need for patient counseling, flexibility in care provision, and a low-threshold approach to treatment, which includes no drug testing, flexible appointments, and supplemental sublingual buprenorphine support. Additionally, the video covers managing side effects, harm reduction strategies, and the challenges in treating stimulant use disorders, with a focus on contingency management. Dr. Spencer presents a case study involving a pregnant woman with multiple substance use issues and mentions upcoming training sessions on buprenorphine prescribing for chronic pain. Attendees engaged in discussions around prescribing stimulants, available resources, and the potential benefits of contingency management programs in treating substance use disorders. The session aimed to educate healthcare providers on evidence-based approaches for addressing substance use disorders and supporting patients with complex needs.

Keywords

Chelsea

indigenous lands

Dr. Sarah Spencer

long-acting injectable buprenorphine

addiction treatment

Alaska

medication benefits

logistical aspects

patient satisfaction

transitioning

patient counseling

flexibility in care provision

low-threshold approach